Capillary Blood Collection Devices Market Summary
As per Market Research Future Reports analysis, the Capillary Blood Collection Devices Market size was valued at USD 3.634 Billion in 2024. The market is projected to grow from USD3.828 Billion in 2025 to USD6.433 Billion by 2035, exhibiting a CAGR of 5.3% during the forecast period 2025–2035. North America led the market with over 44.03% share, generating around USD 1.6 billion in revenue.
Increasing demand for minimally invasive diagnostic techniques and rapid point-of-care testing is a major growth factor, enabling early Alzheimer’s detection, improving patient compliance, enhancing diagnostic efficiency, and supporting healthcare systems in delivering timely and accurate neurological assessments globally.
According to the Centers for Disease Control and Prevention (CDC), over 6.7 million people aged 65 and above in the U.S. are living with Alzheimer’s in 2023, supporting increased demand for accessible and early diagnostic solutions.
Key Market Trends & Highlights
The Capillary Blood Collection Devices Market is experiencing robust growth driven by technological advancements and increasing demand for home healthcare solutions.
- North America leads with over 44.03% share in 2024, supported by advanced diagnostic infrastructure and strong healthcare spending.
- Market projected to grow from USD 3.634 billion in 2024 to USD 6.433 billion by 2035 at 5.3% CAGR.
- Increasing adoption of minimally invasive and point-of-care diagnostic devices is enhancing accessibility and improving early Alzheimer’s detection outcomes globally.
- Rising geriatric population and growing preference for home healthcare solutions are accelerating demand for convenient and rapid diagnostic technologies worldwide.
Market Size & Forecast
| 2024 Market Size | 3.634 (USD Billion) |
| 2035 Market Size | 6.433 (USD Billion) |
| CAGR (2025 - 2035) | 5.33% |
Major Players
Companies such as Thermo Fisher Scientific (US), BD (US), F. Hoffmann-La Roche Ltd (CH), Abbott Laboratories(US), Siemens Healthineers (DE), Greiner Bio-One International (AT), Sarstedt AG & Co. (DE), HemoCue AB (SE), Cypress Diagnostics (BE) are some of the major participants in the global market.